In the Press

Click on the sections below to view each press article for each year.

2015

New drugs to help CF and bronchiectasis patients (rte.ie)

Basilea Working With European Antibiotics Project To Develop BAL30072 For Bronchiectasis, CF (bronchiectasisnewstoday.com)

BRONCH-UK - Bronch-UK researchers contributing to €50m programme to develop new antibiotic treatments for cystic fibrosis and bronchiectasis.

Queen's leads €50 million program to dev | EurekAlert!

Inhaled dosage form of BAL30072 to be formulated (drugtargetreview.com)

New Version of Inhaled Antibiotic for Infections in Bronchiectasis, CF Being Developed (lungdiseasenews.com)

Europeans team up to develop antibiotics for lung infections (healio.com)
2016
Basilea drops inhaled antibiotic, expands cancer program in early-stage rejig | Fierce Biotech
2017
Inhaled Antibiotic for CF, Bronchiectasis Under Development | RT (rtmagazine.com)

Polyphor launches the development of an inhaled antibiotic murepavadin (europeanpharmaceuticalreview.com)

Polyphor AG: Polyphor Launches the Development of an Inhaled Formulation of its Antibiotic Murepavadin (pharmasalmanac.com)

Polyphor starts project for inhaled antibiotic therapy for chronic infections (startupticker.ch)

Polyphor Pursues Promise Of Inhaled Antibiotics To Tackle Lung Infections :: Medtech Insight (informa.com)

O’Neill Review - Hansard - UK Parliament

Preclinical Data Shows Potential of Murepavadin Against P. Aeruginosa (bronchiectasisnewstoday.com)
2019
Alaxia Partners with iABC to Speed Development of ALX-009 (cysticfibrosisnewstoday.com)

Alaxia joins consortium to speed ALX-009 development (thepharmaletter.com)

Alaxia joins EU consortium to combat drug-resistant lung infections | Andrew Lloyd & Associates

Alaxia Joins iABC Consortium to Accelerate Development of ALX-009 (bronchiectasisnewstoday.com)
2020
Polyphor Receives Approval to Start First-in-Human Clinical (globenewswire.com)

<<< News

>>> Press Releases